1. Home
  2. KRYS vs JBTM Comparison

KRYS vs JBTM Comparison

Compare KRYS & JBTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$279.67

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Logo JBT Marel Corporation

JBTM

JBT Marel Corporation

HOLD

Current Price

$164.13

Market Cap

8.1B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRYS
JBTM
Founded
2015
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.8B
8.1B
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
KRYS
JBTM
Price
$279.67
$164.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
2
Target Price
$257.45
$180.00
AVG Volume (30 Days)
249.5K
452.0K
Earning Date
02-17-2026
02-25-2026
Dividend Yield
N/A
0.24%
EPS Growth
275.72
N/A
EPS
6.66
N/A
Revenue
$373,164,000.00
$3,257,800,000.00
Revenue This Year
$36.10
$124.13
Revenue Next Year
$42.21
$4.45
P/E Ratio
$41.50
N/A
Revenue Growth
54.51
92.43
52 Week Low
$122.80
$90.08
52 Week High
$295.98
$170.19

Technical Indicators

Market Signals
Indicator
KRYS
JBTM
Relative Strength Index (RSI) 55.88 54.20
Support Level $264.85 $162.31
Resistance Level $280.00 $169.76
Average True Range (ATR) 11.47 5.05
MACD -1.66 -0.24
Stochastic Oscillator 49.97 54.51

Price Performance

Historical Comparison
KRYS
JBTM

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About JBTM JBT Marel Corporation

JBT Marel Corp is a technology solutions provider to segments of the food and beverage industry. It designs, produces, and services products and systems for a broad range of end markets, generating roughly one-half of annual revenue from recurring parts, services, rebuilds, and leasing operations.

Share on Social Networks: